Pretty standard negativity with inflammatory language.
they mention:
covid 19 trial being pulled - not going to meet primary objectives
mixed results for back pain
thrown a life line by surgecenter (threw in the going concern)
collaboration with gruenthal downgraded
the 2011 angioplast furphy
fda still hs concerns over batch consistency
that's about it. nothing positive.
Cell Therapy News/Articles, page-10441
-
- There are more pages in this discussion • 7,603 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
94.0¢ |
Change
-0.020(2.08%) |
Mkt cap ! $1.073B | |||
| Open | High | Low | Value | Volume |
| 95.5¢ | 97.0¢ | 93.5¢ | $1.424M | 1.507M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 29390 | 93.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.5¢ | 14089 | 2 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |